EWP
IDXX icon

Elevation Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

Elevation Wealth Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$18.8K Sell
36
-13
-27% -$7.12K 0.01% 701
2026
Q2 		$25.8K Buy
49
+32
+188% +$17.9K 0.01% 503
2026
Q1 		$9.55K Buy
17
+6
+55% +$3.85K ﹤0.01% 521
2025
Q4 		$7.44K Buy
11
+4
+57% +$2.72K ﹤0.01% 541
2025
Q3 		$4.47K Buy
+7
New +$4.25K ﹤0.01% 500

Other funds holding IDXX

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
BST
Bath Savings Trust Bath, Maine $966M AUM 9.35% 1-Year Est. Return
BRCM
Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
BAM
Bell Asset Management Melbourne, Australia $277M AUM 2.32% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
RSC
Red Spruce Capital Berwyn, Pennsylvania $283M AUM 29.49% 1-Year Est. Return

Elevation Wealth Partners's IDXX Position: Q3 2026 in Review

Elevation Wealth Partners reduced its Idexx Laboratories (IDXX) stake by 27% in Q3 2026, selling an estimated $7.12K and leaving 36 shares worth $18.8K. The position accounts for 0.01% of the portfolio, ranked #701.

Elevation Wealth Partners first reported a position in IDXX in Q3 2025 and has held it in 5 quarters since. The position peaked at $25.8K in Q2 2026. 36 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Elevation Wealth Partners held 36 shares of Idexx Laboratories worth $18.8K as of Q3 2026.
  • Elevation Wealth Partners sold 13 Idexx Laboratories shares in Q3 2026, an estimated $7.12K.
  • Idexx Laboratories made up 0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #701 holding.
  • Elevation Wealth Partners first reported a position in Idexx Laboratories in Q3 2025 and has held it in 5 quarters since.
  • Elevation Wealth Partners's Idexx Laboratories position peaked at $25.8K in Q2 2026.
  • 36 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.